| __timestamp | Amphastar Pharmaceuticals, Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 8494000000 |
| Thursday, January 1, 2015 | 37065000 | 9046000000 |
| Friday, January 1, 2016 | 41199000 | 9095000000 |
| Sunday, January 1, 2017 | 43415000 | 10554000000 |
| Monday, January 1, 2018 | 57564000 | 10775000000 |
| Tuesday, January 1, 2019 | 68853000 | 11355000000 |
| Wednesday, January 1, 2020 | 67229000 | 12340000000 |
| Friday, January 1, 2021 | 60932000 | 14277000000 |
| Saturday, January 1, 2022 | 74771000 | 14135000000 |
| Sunday, January 1, 2023 | 73741000 | 15048000000 |
| Monday, January 1, 2024 | 17232000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, innovation is the lifeblood of progress. Over the past decade, Johnson & Johnson and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting approaches to research and development (R&D) investment. From 2014 to 2023, Johnson & Johnson consistently allocated a significant portion of its resources to R&D, with expenditures peaking at approximately $15 billion in 2023. This represents a steady increase of around 77% from 2014. In contrast, Amphastar Pharmaceuticals, Inc. has shown a more modest growth in R&D spending, reaching about $74 million in 2022, a 162% increase from 2014. While Johnson & Johnson's investment dwarfs that of Amphastar, the latter's rapid growth rate highlights its commitment to innovation. This comparison underscores the diverse strategies companies employ to drive innovation and maintain competitive edges in the pharmaceutical sector.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Research and Development Investment: Johnson & Johnson vs Pfizer Inc.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Amphastar Pharmaceuticals, Inc.
R&D Spending Showdown: Soleno Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Iovance Biotherapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?